Dow Component Johnson & Johnson (JNJ) To Go Ex-dividend Tomorrow

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

The Dow Jones Industrial Average ( ^DJI) is trading up 76 points (+0.5%) at 16,116 as of Thursday, Feb 20, 2014, 10:35 a.m. ET. During this time, 94.5 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 381.2 million. The NYSE advances/declines ratio sits at 1,777 issues advancing vs. 1,064 declining with 176 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Friday, February 21, 2014 is the ex-dividend date for Dow component Johnson & Johnson (NYSE: JNJ). Owners of shares as of market close today will be eligible for a dividend of 66 cents per share. At a price of $92.27 as of 10:35 a.m. ET, the dividend yield is 2.9% compared to the average Dow component yield of 2.6%.

The average volume for Johnson & Johnson has been 8.2 million shares per day over the past 30 days. Johnson & Johnson has a market cap of $260.05 billion and is part of the health care sector and drugs industry. Shares are up 0.6% year to date as of Wednesday's close.

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The company has a P/E ratio of 16.7, below the average drugs industry P/E ratio of 19.2.
  • Practice your dividend trading strategies and win cash in our stock game.

TheStreet Ratings rates Johnson & Johnson as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Video: You Could Live in a Ritz-Carlton or St. Regis Home

Video: You Could Live in a Ritz-Carlton or St. Regis Home